Tactio Integrates MIR SmartOne BTLE Spirometer Opening Up Several Key COPD Deployments via Its Strategic Partnership With DOCAPOST
MONTREAL, October 2, 2017 (Newswire.com) - Tactio Health Group and Medical International Research (MIR), two companies leading the way respectively in telehealth and spirometry, are teaming up to offer a telehealth solution specifically designed to monitor COPD patients remotely. The joint solution adds MIR spirometers to a growing list of Bluetooth-enabled devices that seamlessly integrate with TactioRPM patient apps, enabling data collection without mandating third-party accounts.
300 million people suffer from asthma, over 200 million people worldwide have Chronic Obstructive Pulmonary Disease (COPD). COPD is a type of obstructive lung disease characterized by long-term poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.
MIR SmartOne is a portable FEV1 and Peak Flow meter enabling personal self-tracking of lung health as easily as measuring body temperature with the accuracy of a clinical setting. Lung function reduces much before the symptoms occur, preventing patients from becoming aware of their pathology. Therefore, in addition to COPD diagnosed patients, SmartOne can also be useful for screening or to healthy subjects who can suffer from temporary airway inflammation such as bronchitis, pneumonia and colds.
“With MIR SmartOne, COPD patients being monitored remotely with TactioRPM systems can benefit from an easy and simple way to self-test, report and exchange with their pneumologist. I’ve tried it many times myself and even as a runner with healthy lungs, I was happy to see my lung age which my annual checkups have never revealed before!” said Michel Nadeau, P.Eng., CEO of Tactio Health Group.
TactioRPM is an app-enabled platform that combines mobile apps, hundreds of connected health integrations (including Apple, A&D, Fitbit, Garmin, Google, MIR, Nonin, Omron, Roche & Welch Allyn), patient questionnaires, digital coaching programs and HIPAA-compliant messaging. Powering telehealth initiatives from payers, providers and pharma, its wide range of clinical applications includes chronic disease monitoring, population health screening, clinical research and post-acute care. TactioRPM is registered as a Class 1 with the FDA, CE and ANVISA.
Roberta Di Pinto, MIR International Sales Director, stated, “Working with Tactio is a tremendous opportunity for Mir. The uniqueness of the TactioRPM app empowered patient monitoring is a natural fit for the SmartOne. With its strategic partnership with Docapost the combined solution will reach lots of COPD patients in France, all in need of digital, mobile and connected care solutions that they can use in the comfort of their home such as the SmartOne.”
Docapost leads the eHealth market in France with a broad market access and numerous initiatives. The MIR integration shall immediately provide value to Docapost customers in need of remotely monitoring COPD patients or conducting clinical research with COPD patients that are serviced via the Tactio/Docapost Health Monitoring Platform (TD-HMP) which is an integration of the combined digital assets of Tactio and Docapost. Other clients of Tactio in countries where MIR is available shall also benefit from this integration for their patients.
Tactio and TactioRPM are tradenames of Tactio Health Group. All other trademarks and tradenames used here above are tradenames or trademarks of their respective companies.
About TACTIO – http://www.tactiohealth.com
Tactio Health Group helps innovative healthcare organizations make the patient experience mobile, digital and connected with a telehealth platform that combines the power of apps, health IoT and cloud services. Powering telehealth initiatives from payers, providers and pharma, its wide range of clinical applications includes chronic disease monitoring, population health screening, clinical research and post-acute care. Founded in 2009, Tactio is headquartered in Montreal servicing services payers, providers and pharma through a global network of channel partners in North America, Europe and South America. Tactio health apps have been downloaded by more than 4.5 million users in 135 countries and 17 languages.
About MIR – http://www.spirometry.com
Since 1993, MIR Italy designs, develops, manufactures and distributes a highly technological, innovative and comprehensive range of portable spirometers, oximeters and solutions for telemedicine, clinical trials and patient self-monitoring. The cornerstone of MIR spirometry technology is the FlowMIR disposable turbine. User-friendliness makes all our devices ideal for both specialists and family doctors. MIR is one of the most active companies in the world for emerging trends like wireless real-time health monitoring and truly mobile instruments for personal care providing fast and intuitive solutions for modern professionals. MIR continues to strive for advancement of spirometry technology with many new products on the horizon reflecting the evolving needs of modern healthcare. Today MIR, Medical International Research, is present in more than 93 countries worldwide.
About DOCAPOST – http://www.docapost.com
As a subsidiary of Le Groupe La Poste, Docapost assists companies with their digital and mobile transformation process. Docapost enables companies, local authorities and administrations to optimize and digitize their business processes and their relations with customers, employees, suppliers and citizens. Docapost offers tailormade and turnkey solutions combining consulting with the joint creation of innovative products and services. Docapost has nearly 5,000 employees dotted across 60 sites in France and generated revenues of €455m in 2016. Docapost also operates in numerous other countries, including the United States, the United Kingdom, Spain and Mexico. Docapost’s products and services are audited and certified by independent organisations to ensure full reliability.
MIR Group Press Contact
+39 6 22754777 / +39 338 932 2581
La Poste Group Press Department
+33 (0)1 54 44 22 37 / +33 (0)6 42 27 09 77
- DOCAPOST Press Contact
+33 (0)1 41 34 20 97
Tactio Press Contact
+1 514-657-7628 x787
Source: Tactio Health Group